Filed by ReShape Lifesciences Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: ReShape Lifesciences Inc.
Commission File No.: 001-37897
IMPORTANT ALERT
We adjourned the Special Meeting to approve our transaction with Vyome Therapeutics to August 7th to provide more time for ReShape shareholders to vote on Proposals 2 & 3.
Proposal 2 (approval of proposed asset sale) and Proposal 3 (approval of proposed charter amendment) each require the affirmative vote of a majority of the outstanding shares. Not voting will have the same effect as a vote against Proposals 2 & 3.
PLEASE DO NOT DELAY--VOTING IS QUICK AND EASY!
Our proxy solicitor, Innisfree, can take your vote directly by phone or
help with any questions that you may have about the Special Meeting. Please call:
Toll-free: (877) 717-3905 (from the U.S and Canada) or
+1 (412) 232-3651 (from other locations)
10:00 am-7:00 pm ET, Monday-Friday; 10:00am-2:00pm ET, Saturday
TIME IS SHORT—PLEASE DO NOT DELAY!
PLEASE CALL TODAY TO VOTE BY TELEPHONE
OR FOR HELP WITH ANY QUESTIONS
YOU MAY HAVE ABOUT THE SPECIAL MEETING.
(SEE REVERSE FOR VOTING DETAILS)